Table 1. Selected US CDC global health protection platform accomplishments*.
| Global health protection accomplishments | Number | Timeframe |
|---|---|---|
| Emergency mitigation of global health threats | ||
| Ending the West Africa Ebola outbreak | ||
| CDC staff deployments overall, domestic and international | >3,500 | 2014–2016 |
| Departing passengers in the 3 affected countries screened for Ebola virus disease | >339,000 | 2014–2016 |
| Vaccinations of health workers in Ebola trial | >8,000 | 2015 |
| Days of continuous operation of high-throughput laboratory capacity in Sierra Leone; >23,000 specimens tested | 421 | 2014–2015 |
| US healthcare workers trained in Anniston, AL, to work in West Africa | >600 | 2015 |
| GRRT | ||
| CDC-trained GRRT experts prepared to deploy on short notice to a public health emergency | >400 | 2017 (Jun) |
| GRRT mobilizations (>14,000 cumulative person-days), supporting responses to global health emergencies including Zika, yellow fever, cholera, measles, polio, and Ebola | >420 | 2015–2017 (Jun) |
| Rapid humanitarian responses | ||
| Staff deployments in response to public health humanitarian emergencies in >40 countries | >380 | 2011–2016 |
| Staff deployments to 6 countries in response to Syria crisis | 85 | 2012–2016 |
| Countries with morbidity/mortality surveillance systems implemented in response to Horn of Africa famine | 3 | 2011–2012 |
| PHEM program | ||
| Fellows from 28 countries trained through CDC PHEM fellowship | 69 | 2013–2017 (Jun) |
| Countries that have received CDC emergency management technical assistance and training | 56 | 2013–2016 |
| Countries that participated in a real and/or simulated response with CDC technical assistance | 19 | 2013–2016 |
| Global Disease Detection Operations Center | ||
| Serious public health threats assessed | >1,500 | 2007–2016 |
| Countries where serious outbreaks were investigated/contained, where CDC provided technical assistance | >190 | 2007–2016 |
| Unique diseases tracked globally | >170 | 2007–2016 |
| Outbreaks monitored and reported in >130 countries for ≈40 different diseases | ≈300 | 2016 |
| GDD activities | ||
| GDD regional centers | 10 | 2006–2016 |
| New diagnostic tests established in national or regional laboratories | >380 | 2006–2016 |
| New strains/pathogens detected and/or discovered (new to the world, new to country or region, or new modes of transmission likely because of increased ability to detect through newly introduced laboratory tests) in which GDD assisted in detection and identification | 79 | 2006–2016 |
| Outbreaks responded to by GDD center that provided epidemiology and/or laboratory assistance | 2,051 | 2006–2016 |
| Outbreak investigations in which laboratory support was provided | 1,363 | 2006–2016 |
| Participants who received public health trainings conducted at national and/or regional level on topics, including epidemiology, laboratory, all-hazards preparedness, and risk communication |
115,566 |
2006–2016 |
| Capacity-building partnerships to contain threats at the source | ||
| GHSA implementation | ||
| GHSA countries: 17 Phase I countries, 14 Phase II countries, and CARICOM† | >31 | 2015–2017 (Mar) |
| Phase I countries with enhanced surveillance systems for zoonotic diseases | 13 | 2015–2017 (Mar) |
| Countries that detected dangerous pathogens using new equipment and capabilities | 16 | 2015–2017 (Mar) |
| Phase I countries supported in development of Emergency Operations Centers | 16 | 2015–2017 (Mar) |
| Joint External Evaluation | ||
| GHSA assessments conducted before tool finalization | 6 | 2016 |
| Evaluations completed | 52 | 2016–2017 (Jul) |
| Public health workforce development | ||
| Countries with CDC-supported FETPs | 65 | 1980–2016 |
| Graduates of FETPs-Advanced | >3,900 | 1982–2016 |
| Outbreaks investigated by FETPs-Advanced trainees | >3,300 | 2005–2016 |
| New FETPs-Frontline started | 24 | 2014–2016 |
| Participants in FETPs-Frontline | >1,860 | 2015–2016 |
| Global vaccine-preventable disease activities | ||
| STOP program volunteers trained in surveillance principles to detect and respond to cases of polio and other vaccine-preventable diseases | 2,010 | 1998–2017 (Jul) |
| Countries with volunteers deployed for the STOP program | 77 | 1998–2016 |
| Countries supported by CDC to build national STOP programs | 4 | 1998–2016 |
| NPHIs | ||
| Members of International Association of National Public Health Institutes and supported by CDC | >100 | 2016 |
| Countries receiving NPHI development support from CDC | >20 | 2016 |
| Persons across the globe served by NPHIs | 5 billion | 2016 |
*CARICOM, Caribbean Community; CDC, Centers for Disease Control and Prevention; FETP, field epidemiology training program; GDD, Global Disease Detection; GHSA, Global Health Security Agenda; GRRT, Global Rapid Response Team; NPHI, National Public Health Institute; PHEM, public health emergency management; STOP, Stop Transmission of Polio. †CARICOM is an organization of 15 Caribbean nations and dependencies. In 2015, the US government committed to accelerating GHSA implementation with 31 countries and CARICOM (Figure 1). In 17 Phase I, 14 Phase II, and CARICOM nations (Figure 1), CDC provides technical assistance to support country capacity assessments, the development of 5-year GHSA road maps, and annual GHSA implementation plans. In the Phase I countries, CDC also provides financial support for implementation of the GHSA action packages (Table 2) (14–16).